Innate Pharma (IPHA) EBT Margin (2020 - 2024)
Innate Pharma (IPHA) reported EBT Margin of 391.94% for Q4 2024, down 37736.0% on a YoY basis from N/an in Q1 2024, and down 31.25% quarter-over-quarter from 298.61% in Q2 2024.
Innate Pharma (IPHA) EBT Margin (2020 - 2024) Analysis & Trends
Innate Pharma has reported EBT Margin for 5 years, with the latest figure at 391.94% in Q4 2024.
- For the quarter ending Q4 2024, EBT Margin fell 37736.0% year-over-year to 391.94%; the trailing twelve-month figure through Dec 2024 stood at 75.15% (down 4610.0% YoY), and the FY2025 full-year result was 1764.51%, down 151865.0% from the prior year.
- EBT Margin for Q4 2024 stood at 391.94%, down from 298.61% in the prior quarter.
- The five-year high for EBT Margin was 10.33% in Q2 2023, with the low at 391.94% in Q4 2024.
- Historically, EBT Margin has averaged 125.78% across 5 years, with a median of 14.59% in 2023.
- Annual changes were most pronounced in 2022 — EBT Margin surged 18400 bps — and 2024, when it sank 37736 bps.
- Innate Pharma's EBT Margin stood at 1.48% in 2020, then sank by 12371 bps to 184.1% in 2021, then jumped by 100 bps to 0.1% in 2022, then sank by 14410 bps to 14.59% in 2023, then plunged by 2587 bps to 391.94% in 2024.
- The last three EBT Margin figures came in at 391.94% (Q4 2024), 298.61% (Q2 2024), and 14.59% (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 6.40% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Innate Pharma | 194.19 Mn | 194.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -391.94% |
| Jun 30, 2024 | -298.61% |
| Dec 31, 2023 | -14.59% |
| Jun 30, 2023 | 10.33% |
| Dec 31, 2022 | -0.10% |
| Dec 31, 2021 | -184.10% |
| Dec 31, 2020 | -1.48% |